Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesOtorhinolaryngology (ENT)Centene nasal valve repair Coverage Update | OpenP…
    Ask Trek AI about this page
    ModifiedCentenePolicy CP MP.210

    Repair of Nasal Valve Compromise

    Customize your policy alerts

    Sign up for Centene Policy CP MP.210 alerts

    Get alerted when Policy CP MP.210 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical necessity guidelines for surgical and device-based repair of nasal valve compromise (internal and external) for members of Centene-affiliated health plans; describes covered procedures, excluded procedures, and required diagnostic/supporting evidence.

    Policy Summary
    PayerCentene
    PolicyRepair of Nasal Valve Compromise
    Policy CodePolicy CP MP.210
    Change TypeMaterial—added conservative therapy examples and added CPT 30469 to not supported codes
    Effective Date
    Next Review Date
    Key ActionDocument a trial of conservative management (e.g., nasal cones, external nasal dilator strips, or nasal dilators such as Max-Air Nose Cones and Sinus Cones) prior to surgical repair.
    SourceLink
    POLICY UPDATE CHANGES

    Added nasal dilators such as Max-Air Nose Cones and Sinus Cones to conservative treatment examples in criteria I.B and I.D.

    CPT code 30469 (radiofrequency remodeling) added to Codes That Do Not Support Coverage.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    1CPT code supporting coverage
    2CPT codes not supporting coverage
    3Distinct excluded procedures
    13%Estimated NVC in chronic obstruction

    Coverage Criteria — Repair of Nasal Valve Compromise

    inv-01: Medically Necessary — Repair of Nasal Valve Compromise

    Covered when ALL of the following are met:

    Entry criteria: 1) Clinical finding of internal nasal valve compromise (collapse/compromise of the upper lateral cartilage) OR external nasal valve compromise (collapse of the lower lateral cartilage).

    Documented by physical exam and/or maneuvers (see required documentation).

    Symptom and functional response: 2) Member reports obstructed breathing that improves with lateralization/Cottle maneuver or with an outpatient trial of external stents or nasal dilators (examples: Breathe Right strips, Max-Air Nose Cones, Sinus Cones) or with lateralization of the upper lateral cartilage from inside the nose (e.g., with a cotton swab or nasal speculum).

    Improvement should be documented in the clinical record.

    Exclusion of other causes: 3) Other causes of nasal obstruction have been evaluated and reasonably excluded (e.g., sinusitis, allergic or nonallergic rhinitis, nasal polyps, adenoid hypertrophy, nasopharyngeal masses, septal deviation, turbinate hypertrophy).

    Documentation of evaluation and findings required.

    Conservative therapy requirement: 4) Symptoms persist despite an adequate course of conservative therapy (examples: nasal cones, external nasal dilator adhesive strips, or a six-week trial of intranasal steroids).

    Conservative treatments attempted and dates/response must be documented.

    Operational note: Providers must document each of the above elements in the medical record to meet medical necessity for repair of nasal valve compromise.

    inv-02: Not Established / Experimental Procedures for Nasal Vestibular Stenosis

    The following procedures/devices have not established safety and efficacy for repair of nasal vestibular stenosis:

    Not established procedures: A) Radiofrequency ablation (VivAer) ; B) Absorbable nasal implants (Latera) ; C) Nasal valve suspension surgery.any

    These procedures/devices are considered to lack established safety and/or efficacy per the policy and evidence reviews.

    The policy identifies specific procedures and devices for which the available evidence is insufficient to establish safety and efficacy for repair of nasal vestibular stenosis. Per the evidence reviews cited in the source material, VivAer (low-energy radiofrequency remodeling) has only minimal support from clinical studies of mixed and generally poor quality, with uncertain effects on objective measures of nasal patency and no direct comparisons to active treatments. Similarly, absorbable nasal implants (Latera) are technically feasible and may reduce patient-reported obstruction in some uncontrolled studies, but the evidence base is generally very poor, lacks adequate control groups, and provides limited long-term follow-up. For these reasons the policy considers VivAer and Latera to have insufficient evidence to be established treatments for nasal valve repair and does not support their routine use for this indication.

    Coverage determinations under this clinical policy are guidance to assist in making medical necessity decisions and administering benefits; they do not constitute a contract or guarantee of payment. All coverage decisions remain subject to the member’s specific plan terms, conditions, exclusions and limitations, as well as applicable state and federal requirements and Health Plan-level administrative policies and procedures. When program-specific rules (for example, state Medicaid manuals or Medicare NCDs/LCDs) conflict with this policy, the applicable program requirements take precedence.

    The policy distinguishes covered surgical repair techniques from procedures and devices that lack established efficacy. It notes that radiofrequency remodeling (VivAer) is an office‑based, low‑energy RF treatment intended to stiffen and reposition intranasal soft tissues but that clinical evidence is limited and of variable quality. The policy also describes absorbable implants (Latera) as an endonasally placed, absorbable lateral wall implant that is replaced over time by fibrous tissue, but available studies are generally poor in quality and insufficient to demonstrate long‑term clinical benefit. Finally, nasal valve suspension surgery is listed among procedures without established safety and efficacy for nasal vestibular stenosis. These named procedures/devices are therefore considered not supported by the policy for routine repair of nasal valve compromise.

    Coding — CPT and Related Codes

    CPT Codes That Support Coverage CriteriaCPTCovered
    30465Repair of nasal vestibular stenosis spreader grafting, lateral nasal wall reconstruction
    CPT Codes That Do Not Support Coverage CriteriaCPTNot Covered
    30468Repair_of_nasal_valve_collapse_with subcutaneous/submucosal lateral wall implant(s)
    30469Repair of nasal valve collapse with low energy, temperature-controlled (i.e,, radiofrequency) subcutaneous/submucosal remodeling

    Provider Actions — Authorization, Documentation, and Denials

    Prior Authorization

    Prior authorization required for CPT 30465

    Prior authorization is required for procedures to repair nasal vestibular stenosis that meet the policy's coverage criteria; CPT code 30465 (Repair of nasal vestibular stenosis spreader grafting, lateral nasal wall reconstruction) supports coverage when all policy criteria are met.

    • Prior authorization required when submitting CPT 30465 for repair of nasal vestibular stenosis.
    Note

    Policy guides coverage decisions; follow plan administrative rules

    This clinical policy is intended to provide medical necessity guidance to assist in making coverage decisions and administering benefits; providers should follow applicable Health Plan-level administrative policies and prior authorization processes when seeking coverage.

    • Policy is guidance—not a guarantee of payment; follow Health Plan administrative policies and prior authorization requirements.

    Background — Nasal Valve Compromise

    Nasal valve compromise (NVC) refers to structural narrowing of the nasal inlet that impedes airflow and contributes to chronic nasal obstruction. NVC may result from weakness or collapse of the upper lateral cartilage (internal nasal valve) or collapse of the lower lateral cartilage/alar rim (external nasal valve), and can arise from trauma, prior surgery, chronic inflammation, congenital anatomy, or age‑related changes. Symptoms commonly include difficulty inhaling through the nose, nasal congestion, and snoring; objective assessment can include exam maneuvers such as the Cottle or lateralization test, patient‑reported outcome measures (e.g., NOSE score), rhinomanometry, endoscopy, or CT when indicated. The policy notes that up to 13% of patients evaluated for chronic nasal obstruction may have nasal valve compromise, underscoring the clinical relevance of accurate diagnosis and documentation.

    Definitions and Provider Responsibilities

    Internal nasal valve compromise — definition and exam maneuvers
    DefinitionCollapse or compromise of the upper lateral cartilage resulting in internal valve obstruction
    Exam maneuversCottle's maneuver: widening the nasal valve angle by pulling laterally on the cheeks and assessing for improvement in nasal breathing
    Instrument-based testBachman's maneuver: widening and stabilizing the nasal valve using instruments simulating the effect of a surgical procedure while assessing subjective impact on nasal breathing
    Supportive testsNOSE score, rhinomanometry, acoustic rhinometry, nasal endoscopy, anterior rhinoscopy, peak nasal airflow, CT of nose/sinuses
    External nasal valve compromise — definition and clinical features
    Definition
    Policy Summary
    PayerCentene
    PolicyRepair of Nasal Valve Compromise
    Policy CodePolicy CP MP.210
    Change TypeMaterial—added conservative therapy examples and added CPT 30469 to not supported codes
    Effective Date
    Next Review Date
    Key ActionDocument a trial of conservative management (e.g., nasal cones, external nasal dilator strips, or nasal dilators such as Max-Air Nose Cones and Sinus Cones) prior to surgical repair.
    SourceLink
    On This Page
    Coverage Criteria — Repair of Nasal Valve CompromiseCoding — CPT and Related CodesProvider Actions — Authorization, Documentation, and DenialsBackground — Nasal Valve CompromiseDefinitions and Provider Responsibilities
    Step Therapy

    Document prior conservative therapy trial(s)

    Providers must document that symptoms persisted despite conservative management. Acceptable conservative therapy examples include nasal cones, external nasal dilator adhesive strips (e.g., Breathe Right), a six‑week trial of nasal steroids, or outpatient nocturnal trials of nasal dilators such as Max‑Air Nose Cones and Sinus Cones.

    • Document trial and response to at least one conservative therapy (nasal cones, external dilator strips, six‑week nasal steroid trial, or nasal dilators such as Max‑Air Nose Cones and Sinus Cones).
    Note

    No specific action listed

    No additional provider action specified in source document for this placeholder; follow the other listed documentation and authorization requirements in this policy.

    Documentation Required

    Required clinical history, exam, and test documentation

    Clinical documentation must include a thorough history and physical exam of the nose and nasopharynx and results of indicated maneuvers/tests (e.g., Cottle's maneuver, Bachman's maneuver, NOSE score, rhinomanometry, nasal endoscopy, and CT if obtained). Documentation must also show that other causes of obstruction were ruled out and record prior conservative therapy trials.

    • Include time course, laterality, triggers, trauma/surgical history, and relevant medical history in the record.
    • Record results of Cottle's maneuver, Bachman's maneuver, NOSE score, rhinomanometry, nasal endoscopy, CT if obtained, and documentation excluding other causes of obstruction.
    • Document prior conservative therapies and their duration/response.
    Note

    Follow payer- and program-specific precedence and guidance

    When state Medicaid provisions conflict with this policy, state Medicaid coverage provisions take precedence; for Medicare members, review all applicable NCDs, LCDs, and Medicare Coverage Articles to ensure consistency with this policy before making coverage determinations.

    • Refer to the state Medicaid manual for Medicaid coverage provisions that may supersede this policy.
    • Review applicable Medicare NCDs, LCDs, and Coverage Articles on the CMS website for Medicare members.
    Denial Risk

    Denial triggers for insufficient documentation or non‑covered codes

    Claims or authorization requests may be denied if documentation does not meet all clinical criteria — including objective findings of internal or external valve compromise, positive response to Cottle or lateralization maneuvers or outpatient trial of stents/dilators, exclusion of other causes of obstruction, and documented persistence despite conservative therapy — or if procedures/CPT codes listed as not supporting coverage (e.g., 30468, 30469) are used.

    • Denial risk if objective valve compromise is not documented or if maneuvers/tests do not demonstrate improvement.
    • Denial risk if other causes of obstruction are not ruled out or conservative therapy trials are not documented.
    • Denial risk if CPT codes 30468 or 30469 (listed as not supporting coverage) are billed for repair.
    Billing Rule

    Decisions subject to coverage documents, exclusions, and limitations

    Coverage decisions and the administration of benefits are subject to all terms, conditions, exclusions, and limitations of the coverage documents; failure to meet those contractual terms may result in denial of coverage.

    • Decisions are governed by evidence of coverage, certificates of coverage, policy contracts, and applicable state and federal requirements.
    • Contractual exclusions and limitations in the member's coverage document may override policy indications.
    Collapse of the lower lateral cartilage (alar rim) leading to external nasal valve obstruction
    Clinical featureManifest as external alar rim collapse producing obstructed nasal breathing
    DifferentiationMust be distinguished from internal valve compromise (upper lateral cartilage collapse) and other causes of obstruction
    Medical necessity guidance — limitations and intent
    PurposeProvides guidance to assist in making coverage decisions and administering benefits
    Not a guaranteeThis guidance does not constitute a contract or guarantee of payment or results
    ScopeCoverage decisions remain subject to all terms, conditions, exclusions and limitations of coverage documents and applicable laws
    Provider responsibility
    Independent judgmentProviders are expected to exercise professional medical judgment in providing the most appropriate care
    ResponsibilityProviders are solely responsible for the medical advice and treatment of members/enrollees
    Policy roleThe policy is not intended to dictate clinical practice or recommend specific treatment for individual members